Pharmacovigilance

Astrapharm Company guarantees the quality, efficiency and safety of the products. To do this, we regularly monitor our customers’ reviews and collect information from pharmacists, consulting physicians, and consumers who deal with our products. Astrapharm pharmacovigilance meets the requirements of the Order of the Ministry of Health of Ukraine dated 26.12.2006 No. 898 “On Approval of the Procedure for Supervision over Adverse Drug Reactions of Medicinal Products Permitted for Medical Use”.

Dear healthcare professionals and consumers of medicines!

If you have information about side effects or lack of efficacy of medicines manufactured by Astrapharm, we suggest you fill out the form below or report the information in any way convenient for you.

1. Message information





MESSAGE SOURCE INFORMATION












SENDER DATA













NoYes

2. Patient information









Information in the event of patient death





3. Data from laboratory and instrumental studies regarding adverse reactions




4. Other medical information

Important medical information

Diagnosis Accompanying illnesses Allergy Pregnancy
Add

Disease







5. Adverse reactions/lack of effectiveness

Description of the case of an adverse reaction/indication of lack of effectiveness (Each manifestation of an adverse reaction and remedy should be described separately)
















Add

6. Medicines

Suspected drugs

Medicines Release form Manufacturer, name Indications for appointment Input method Single dose Frequency rate of acceptance
Add





Correction tools





Concomitant medications?

Medicine Release form Manufacturer, name Indications for appointment Input method Single dose Frequency rate of acceptance
Add





YesNo

YesNo

1. Message information





MESSAGE SOURCE INFORMATION












SENDER DATA













NoYes

2. Patient information









3. Data from laboratory and instrumental studies regarding adverse reactions




4. Other medical information









5. Adverse reactions/lack of effectiveness

Description of the case of an adverse reaction/indication of lack of effectiveness (Each manifestation of an adverse reaction and remedy should be described separately)










Add

6. Medicines

Suspect drug

Medicine Suspect drug Indications for appointment Input method Single dose Frequency rate of acceptance
Add





Correction tools





Related drugs

Medicine Release form Manufacturer, name Indications for appointment Input method Single dose Frequency rate of acceptance
Add





YesNo

YesNo

In our team, real professionals are responsible for pharmacovigilance.

You can contact the pharmacovigilance department at:

E-mail: astrapharmsur@ukr.net

or by calling: +380 (44) 239–08–99

We will maintain your privacy. Any personal information you provide to us about the use of our drugs will not be disclosed without your consent. Exceptions are cases established by law.